Suppression of matrix metalloproteinase-9 production from neutrophils by a macrolide antibiotic, roxithromycin, in vitro
BACKGROUND: Macrolide antibiotics such as erythromycin and roxithromycin (RXM) have an anti-inflammatory effect that may account for their clinical benefit in the treatment of chronic airway inflammatory diseases. However, the precise mechanism of this anti-inflammatory effect is not well understood...
Saved in:
Main Authors: | Ken-Ichi Kanai, Kazuhito Asano, Tadashi Hisamitsu, Harumi Suzaki |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2004-01-01
|
Series: | Mediators of Inflammation |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09629350400008810 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Suppressive Activity of a Macrolide Antibiotic, Roxithromycin, on Pro-Inflammatory Cytokine Production in Vitro and in Vivo
by: H. Suzaki, et al.
Published: (1999-01-01) -
Suppressive activity of macrolide antibiotics on nitric oxide production by lipopolysaccharide stimulation in mice
by: Hajime Terao, et al.
Published: (2003-01-01) -
Influence of a macrolide antibiotic, roxithromycin, on mast cell growth and activation in vitro
by: Toshikazu Shimane, et al.
Published: (2001-01-01) -
Suppression of Matrix Metalloproteinase Production in Nasal Fibroblasts by Tranilast, an Antiallergic Agent, In Vitro
by: Toshiyuki Shimizu, et al.
Published: (2005-01-01) -
Suppressive Activity of Vitamin D3 on Matrix Metalloproteinase Production From Cholesteatoma Keratinocytes In Vitro
by: Hitome Kobayashi, et al.
Published: (2005-01-01)